A meta-analysis, encompassing a total of 16 studies and 3,962 COVID-19 patients, has revealed that individuals with non-severe cases of the virus exhibited significantly lower levels of high-sensitivity HS-CRP when contrasted with those in the severe group (25). This evidence concerns the gene CRP and COVID-19.